Novavax, Inc.

United States of America


 
Total IP 155
Total IP incl. subs 176 (+ 25 for subs)
Total IP Rank # 8,370
IP Activity Score 3/5.0    151
IP Activity Rank # 4,557
IP AS incl. subs 2.7/5.0    171
Stock Symbol
ISIN US6700024010
Market Cap. 1,500M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

44 15
13 17
52 10
4
 
Last Patent 2025 - Coronavirus vaccine formulations
First Patent 1987 - Method of manufacturing unilamel...
Last Trademark 2023 - CHOOSE TO PROTECT
First Trademark 2006 - NOVAVAX

Subsidiaries

1 subsidiaries with IP (11 patents, 14 trademarks)

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Methods and compositions for treating respiratory disease. Disclosed herein are methods and nano...
Invention Sars-cov-2 vaccine compositions. Disclosed herein are coronavirus (CoV) Spike(S) polypeptides, i...
Invention Sars-cov-2 vaccine compositions. Disclosed herein are coronavirus (CoV) Spike (S) polypeptides, i...
Invention Coronavirus and influenza compositions and methods for using them. An immunogenic composition for...
Invention Coronavirus and influenza compositions and methods for using them. An immunogenic composition fo...
Invention Rsv f vaccine formulations. Disclosed herein are RSV F glycoproteins and nanoparticles comprising...
Invention Multivalent influenza nanoparticle vaccines. Disclosed herein are multivalent nanoparticle vacci...
2023 G/S Pharmaceutical preparations for the treatment of infectious diseases and vaccine preparations and...
Invention Downstream process for purification of viral proteins with hydrophobic membrane domain for use in...
Invention Ace2 inhibition assay for evaluation of vaccine immunogenicity. An improved assay to measure immu...
Invention Pseudovirus based neutralization assay for evaluating vaccine immunogenicity. Provided herein are...
G/S Vaccines Providing medical and scientific research information in the field of vaccines, biomedic...
G/S Vaccines. Providing medical and scientific research information in the field of vaccines, biomed...
Invention Compositions and methods for inducing an immune response against epstein-barr virus. Provided her...
2022 Invention Anti-sars-cov-2 spike (s) antibodies and their use in treating covid-19. Infectious diseases rema...
Invention Coronavirus vaccine formulations. Disclosed herein are coronavirus Spike (S) proteins and nanopa...
Invention Coronavirus vaccine formulations. Disclosed herein are coronavirus Spike (S) proteins and nanopar...
G/S Promoting public awareness of the benefits of vaccines; Promoting public awareness of the benefit...
Invention Methods and compositions for treating and preventing malaria. The present disclosure provides im...
Invention Methods and compositions for treating and preventing malaria. The present disclosure provides imm...
G/S Providing medical and scientific research information in the field of vaccines, biomedicine, clin...
G/S Vaccines
Invention Malaria vaccine formulations. Disclosed herein are immunogenic compositions comprising an antige...
Invention Malaria vaccine formulations. Plasmodium Plasmodium parasite. Methods of administering the aforem...
G/S Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants. Pharma...
Invention Modified rsv f proteins and methods of their use. The present invention is generally related to ...
G/S Vaccines.
G/S Pharmaceutical preparations for the treatment of infectious diseases, namely, Covid-19, malaria, ...
G/S Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for me...
G/S Pharmaceutical, biologic, and vaccine research and development; consulting services in the field ...
G/S Pharmaceutical, biologic, and vaccine research and development; consulting services in the field...
G/S Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants. Pharm...
Invention Vaccine compositions having improved stability and immunogenicity. Disclosed herein are nanopart...
Invention Coronavirus and influenza compositions and methods for using them. Disclosed herein are composit...
Invention Coronavirus and influenza compositions and methods for using them. Disclosed herein are compositi...
Invention Corona virus vaccine formulations. Disclosed herein are coronavirus Spike (S) proteins and nanopa...
2021 G/S Vaccines for the treatment and prevention of Covid-19 Providing medical and scientific research i...
G/S Vaccines for the treatment and prevention of Covid-19. Providing medical and scientific research ...
Invention Multivalent influenza nanoparticle vaccines. Disclosed herein are multivalent nanoparticle vaccin...
G/S Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for med...
Invention Clostridium difficile. C. difficile infection. In particular aspects, the compositions are vaccin...
G/S Human vaccines; vaccine adjuvants; pharmaceutical preparations for the treatment of infectious di...
G/S Pharmaceutical preparations for the treatment of infectious diseases, biologic preparations for ...
2020 G/S Human vaccines
Invention Methods for preventing disease or disorder caused by rsv infection. The present invention is gen...
Invention Methods for preventing disease or disorder caused by rsv infection. The present invention is gene...
2019 Invention Modified rsv f proteins and methods of their use. The present invention is generally related to m...
Invention Vaccine compositions having improved stability and immunogenicity. Disclosed herein are nanoparti...
2018 Invention Functional influenza virus like particles (vlps). The present invention discloses and claims viru...
Invention Methods and compositions for treating respiratory disease. Disclosed herein are methods and nanop...
Invention Methods and compositions for inducing immune responses against clostridium difficile. C. difficil...
2017 G/S Human vaccines; vaccine adjuvants Pharmaceutical, biologic, and vaccine research and development;...
G/S Vaccines to prevent respiratory syncytial virus (RSV) and other respiratory illnesses; vaccine ad...
G/S Human vaccines; vaccine adjuvants. Pharmaceutical, biologic, and vaccine research and development...
2015 G/S PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES AND VACCINE PREPARATIONS AND...
G/S PHARMACEUTICAL, BIOLOGIC, AND VACCINE RESEARCH AND DEVELOPMENT; CONSULTING SERVICES IN THE FIELD ...
2006 G/S Pharmaceutical preparations, namely vaccines, hormonal preparations and biologics, related resear...